Please check your internet connection and try again.
## D%2525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520cold
### Overview
D%2525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520cold is a combination product. The specific active ingredients and their strengths are not provided in the drug name. Therefore, detailed dosing and safety information cannot be given without knowing the exact formulation. Common ingredients in "cold" formulations include decongestants (e.g., pseudoephedrine, phenylephrine), antihistamines (e.g., diphenhydramine, loratadine), cough suppressants (e.g., dextromethorphan), and expectorants (e.g., guaifenesin).
### Primary Indications
Symptoms associated with the common cold, such as nasal congestion, cough, sneezing, and runny nose.
### Adult Dosing
Dosing depends entirely on the specific active ingredients and their concentrations. For example:
* **Decongestants:** Pseudoephedrine 30-60 mg every 4-6 hours. Phenylephrine 10-20 mg every 4-6 hours.
* **Antihistamines (first-generation):** Diphenhydramine 25-50 mg every 4-6 hours.
* **Antihistamines (second-generation):** Loratadine 10 mg once daily.
* **Cough Suppressants:** Dextromethorphan 10-20 mg every 4 hours or 30 mg every 6-8 hours.
* **Expectorants:** Guaifenesin 200-400 mg every 4 hours.
Maximum daily doses must be considered for each individual ingredient to avoid toxicity.
### Pediatric Dosing
Pediatric dosing varies significantly by age and weight, and by the specific active ingredients. **Consult specific product labeling or pediatric drug references.** Many formulations are not recommended for young children due to safety concerns.
### Dose Adjustments
Dose adjustments may be necessary for patients with **renal or hepatic impairment**, depending on the active ingredients and their routes of metabolism and excretion. Consult specific drug information for each component.
### Contraindications
Contraindications are ingredient-specific. General contraindications for common components include:
* Hypersensitivity to any ingredient.
* Severe hypertension or cardiovascular disease (for decongestants).
* Narrow-angle glaucoma (for some antihistamines and decongestants).
* Use of MAO inhibitors within the past 14 days (for decongestants).
* Neonates and premature infants (for certain ingredients).
### Adverse Effects
Adverse effects are ingredient-specific. Common effects may include:
* **Decongestants:** Tachycardia, hypertension, insomnia, nervousness, dizziness.
* **Antihistamines:** Sedation, dry mouth, dizziness, confusion (especially in the elderly).
* **Cough Suppressants:** Nausea, vomiting, dizziness, confusion.
* **Expectorants:** Nausea, vomiting, rash.
### Key Drug Interactions
Interactions are ingredient-specific. Important considerations include:
* **MAO inhibitors:** Potentially life-threatening hypertensive crisis with decongestants.
* **CNS depressants (e.g., alcohol, benzodiazepines):** Additive sedation with antihistamines.
* **Other anticholinergic medications:** Increased risk of anticholinergic side effects.
* **CYP2D6 inhibitors:** May increase levels of dextromethorphan.
### Monitoring
Monitor for efficacy in symptom relief and for adverse effects, particularly **blood pressure, heart rate, and signs of CNS depression or stimulation.**
### Clinical Pearls
* Always identify the specific active ingredients and their strengths in any combination "cold" product.
* Be aware of the cumulative dose of ingredients if a patient is taking multiple products containing the same active agents.
* Many combination products are not appropriate for very young children.
* Sedating antihistamines can impair driving and the ability to operate machinery.
***
*Disclaimer: This information is intended for healthcare professionals and is a summary. It is crucial to consult the most current prescribing information, official drug compendia, or relevant guidelines for complete and up-to-date details before making any clinical decisions.*
